NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018

Area of Science:

• Oncology
• Clinical Practice Guidelines

Background:

• Non-Small Cell Lung Cancer (NSCLC) management requires comprehensive, up-to-date guidelines.
• The National Comprehensive Cancer Network (NCCN) provides evidence-based guidelines for cancer care.

Purpose of the Study:

• To summarize recent updates to the NCCN Guidelines for NSCLC.
• To highlight changes in targeted therapy and immunotherapy sections.
• To note the addition of a new biomarker section.

Main Methods:

• Review of the NCCN Guidelines for NSCLC.
• Focus on updates from the 2018 revision.
• Analysis of targeted therapy, immunotherapy, and biomarker sections.

Main Results:

• The 2018 NCCN Guidelines for NSCLC include updates to targeted therapy and immunotherapy recommendations.
• A new dedicated section on biomarkers relevant to NSCLC treatment was introduced.
• These updates aim to refine treatment strategies for NSCLC patients.

Conclusions:

• The NCCN Guidelines continue to evolve, incorporating advancements in NSCLC treatment.
• The inclusion of biomarker information is crucial for personalized NSCLC therapy.
• These updated guidelines support optimal management of Non-Small Cell Lung Cancer.